XaMINA: A Real-World, Prospective, Observational Study of Treatment-Naïve Patients Treated with Rivaroxaban for Stroke Prevention in Atrial Fibrillation in Asia

被引：0
作者：
Ping-Yen Liu
Eue-Keun Choi
Tae-Seok Kim
Jen-Yuan Kuo
Jung Myung Lee
Young Keun On
Sang-Weon Park
Hyung-Wook Park
Dong-Gu Shin
Lili Wang
Hsueh-Wei Yen
Moon-Hyoung Lee
机构：
[1] National Cheng Kung University Hospital,Division of Cardiology, Internal Medicine, College of Medicine
[2] National Cheng Kung University,Department of Internal Medicine
[3] Seoul National University Hospital,Division of Cardiology
[4] The Catholic University of Korea,Department of Medicine
[5] Daejeon St. Mary’s Hospital,Samsung Medical Center
[6] Mackay Memorial Hospital,undefined
[7] Mackay Medical College,undefined
[8] Kyung Hee University Medical Center,undefined
[9] Sungkyunkwan University School of Medicine,undefined
[10] Bucheon Sejong Hospital,undefined
[11] Chonnam National University,undefined
[12] Yeungnam University Medical Center,undefined
[13] Bayer (South East Asia) Pte Ltd,undefined
[14] Kaohsiung Medical University,undefined
[15] Severance Hospital,undefined
[16] Yonsei University,undefined
来源：
Advances in Therapy | 2022年 / 39卷
关键词：
Atrial fibrillation; Rivaroxaban; Stroke; Non-vitamin K antagonist oral anticoagulant; Thrombosis; Real-world evidence; Direct oral anticoagulant;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3316 / 3333
页数：17
相关论文
共 117 条
[1]  
Andrew NE(2013)The prevalence, impact and economic implications of atrial fibrillation in stroke: what progress has been made? Neuroepidemiology 40 227-239
[2]  
Thrift AG(2016)The epidemiology of atrial fibrillation and stroke Cardiol Clin 34 255-268
[3]  
Cadilhac DA(2011)Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 883-891
[4]  
Pistoia F(2011)Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 981-992
[5]  
Sacco S(2009)Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 1139-1151
[6]  
Tiseo C(2013)Edoxaban versus warfarin in patients with atrial fibrillation N Engl J Med 369 2093-2104
[7]  
Patel MR(2016)XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation Eur Heart J 37 1145-1153
[8]  
Mahaffey KW(2018)Real-world use of apixaban for stroke prevention in atrial fibrillation: a systematic review and meta-analysis Stroke 49 98-106
[9]  
Garg J(2021)Non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation patients with concomitant peripheral artery disease Eur Heart J Cardiovasc Pharmacotherap 7 50-58
[10]  
Granger CB(2017)Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation Stroke 48 3040-3048
12345678910